Exelixis Inc at Evercore ISI HealthCONx Virtual Conference Transcript
All right. Welcome, everyone. It's Josh Schimmer from the Evercore ISI biotech team. Pleased to introduce from Exelixis we have Chris Senner, Chief Financial Officer; and Andrew Peters, Senior Vice President of Strategies. Gentlemen, welcome, thanks for joining.
Questions & Answers
Cabo just keeps growing. It's now north of annualizing north of $1 billion. Maybe talk to us a little bit about the primary growth drivers and how sustainable those growth drivers are? And then we'll get into some of the newer emerging growth drivers.
All right. Josh, thanks for having us here, and thanks for the invitation to the conference. Before I get started, just a couple of comments around risk factors and forward-looking statements. So
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
